Albert Science International Organization

ARTICLE DESCRIPTION: 

Dr. Abdul Kader Mohiuddin, Psychiatric Pharmacy: New role of Pharmacists in Mental Health, ASIO Journal of Medical & Health Sciences Research (ASIO-JMHSR), 2019, 3(1): 01-06.

Doi: http://doi-ds.org/doilink/10.2016-74831794/; doi link: http://doi-ds.org/doilink/08.2019-17582516/

ABSTRACT:

Psychiatric disorders are one of the major causes of the global burden of diseases. Stigma remains a major impediment in the delivery of mental healthcare. It has been found across various studies that attitudes of doctors of other specialties and other healthcare professionals also contribute to stigma due to their lack of knowledge and awareness about psychiatry and mental health problems. The number of mental health professionals remains abysmally low. Community pharmacists are accessible, knowledgeable, and capable of providing mental health promotion and care in communities. This may not be a role that is recognized by the public, and men in particular. However, psychotherapy paired with medication is the most effective way to promote recovery. Examples include- Cognitive Behavioral Therapy, Exposure Therapy, Dialectical Behavior Therapy, etc. Pharmacists can play a key role by providing mental health medication management support to improve access and address patients' mental health needs.

Keywords: mental health; mental disorders; social stigma; barriers to access mental health; anxiety and depression.

Google citation                                                               Related articles

1. Mueller L. Changing the Conversation About Mental Health. Chicago Health, September 4, 2018.
2. Harms M, Haas M, Larew J, DeJongh B. Impact of a mental health clinical pharmacist on a primary care mental health integration team. Ment Health Clin. 2018 Mar 23;7(3):101-105. doi: 10.9740/mhc.2017.05.101. eCollection 2017 May. PubMed PMID: 29955506; PubMed Central PMCID: PMC6007568.
3. Rehm J, Shield KD. Global Burden of Disease and the Impact of Mental and Addictive Disorders. Curr Psychiatry Rep. 2019 Feb 7;21(2):10. doi: 10.1007/
4. Faquih AE, Memon RI, Hafeez H, Zeshan M, Naveed S. A Review of Novel Antidepressants: A Guide for Clinicians. Cureus. 2019 Mar 6;11(3):e4185. doi: 10.7759/cureus.4185. Review. PubMed PMID: 31106085; PubMed Central PMCID: PMC6504013.
5. Mulraney M, Hiscock H, Sciberras E, Coghill D, Sawyer M. Mental health difficulties across childhood and mental health service use: findings from a longitudinal population-based study. Br J Psychiatry. 2019 Feb 27:1-6. doi: 10.1192/bjp.2019.32. [Epub ahead of print] PubMed PMID: 30810103.
6. Horackova K, Kopecek M, Mach? V, Kagstrom A, Aarsland D, Motlova LB, Cermakova P. Prevalence of late-life depression and gap in mental health service use across European regions. Eur Psychiatry. 2019 Apr;57:19-25. doi: 10.1016/j.eurpsy.2018.12.002. Epub 2019 Jan 15. PubMed PMID: 30658276.
7. Singh OP. Closing treatment gap of mental disorders in India: Opportunity in new competency-based Medical Council of India curriculum. Indian J Psychiatry. 2018 Oct-Dec;60(4):375-376. doi: 10.4103/psychiatry.IndianJPsychiatry_458_18. PubMed PMID: 30581200; PubMed Central PMCID: PMC6278227.
8. Swaminath G, Enara A, Rao R, Kumar KVK, Kumar CN. Mental Healthcare Act, 2017  and homeless persons with mental illness in India. Indian J Psychiatry. 2019 Apr;61(Suppl 4):S768-S772. doi: 10.4103/psychiatry.IndianJPsychiatry_117_19. Review. PubMed PMID: 31040471; PubMed Central PMCID: PMC6482680.
9. Hayes K, Berry P, Ebi KL. Factors Influencing the Mental Health Consequences of Climate Change in Canada. Int J Environ Res Public Health. 2019 May 6;16(9). pii: E1583. doi: 10.3390/ijerph16091583. PubMed PMID: 31064134; PubMed Central PMCID: PMC6539500.
10. Cook L. Mental health in Australia: a quick guide. Parliament of Australia, 14 February 2019.
11. Satinsky E, Fuhr DC, Woodward A, Sondorp E, Roberts B. Mental health care utilisation and access among refugees and asylum seekers in Europe: A systematic  review. Health Policy. 2019 Feb 22. pii: S0168-8510(19)30039-9. doi: 10.1016/j.healthpol.2019.02.007. [Epub ahead of print] PubMed PMID: 30850148.
12. Pauly JB, Moore TA, Shishko I. Integrating a mental health clinical pharmacy specialist into the Homeless Patient Aligned Care Teams. Ment Health Clin. 2018 Jun 29;8(4):169-174. doi: 10.9740/mhc.2018.07.169. eCollection 2018 Jul. PubMed PMID: 30155391; PubMed Central PMCID: PMC6063462.
13. Shpigelman CN, HaGani N. The impact of disability type and visibility on self-concept and body image: Implications for mental health nursing. J Psychiatr  Ment Health Nurs. 2019 Apr;26(3-4):77-86. doi: 10.1111/jpm.12513. Epub 2019 Mar 26. PubMed PMID: 30793457.
14. Plana-Ripoll O, Pedersen CB, Holtz Y, Benros ME, Dalsgaard S, de Jonge P, Fan  CC, Degenhardt L, Ganna A, Greve AN, Gunn J, Iburg KM, Kessing LV, Lee BK, Lim CCW, Mors O, Nordentoft M, Prior A, Roest AM, Saha S, Schork A, Scott JG, Scott KM, Stedman T, Sørensen HJ, Werge T, Whiteford HA, Laursen TM, Agerbo E, Kessler  RC, Mortensen PB, McGrath JJ. Exploring Comorbidity Within Mental Disorders Among a Danish National Population. JAMA Psychiatry. 2019 Jan 16. doi: 10.1001/jamapsychiatry.2018.3658. [Epub ahead of print] PubMed PMID: 30649197; PubMed Central PMCID: PMC6439836.
15. Yamauchi T, Sasaki T, Yoshikawa T, Matsumoto S, Takahashi M. Incidence of overwork-related mental disorders and suicide in Japan. Occup Med (Lond). 2018 Aug 11;68(6):370-377. doi: 10.1093/occmed/kqy080. PubMed PMID: 29897506.
16. Uhlenbusch N, Löwe B, Härter M, Schramm C, Weiler-Normann C, Depping MK. Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study. PLoS One. 2019 Feb 20;14(2):e0211343. doi: 10.1371/journal.pone.0211343. eCollection 2019. PubMed PMID: 30785907; PubMed Central PMCID: PMC6382125.
17. Rokach A. The Effect of Psychological Conditions on Sexuality: A Review. Psychol Psychother Res Stud. 2(2). PPRS.000534. 2019.  DOI:   10.31031/PPRS.2019.02.000534
18. Gibu M, Clark J, Gold J. Mental health pharmacists as interim prescribers. Ment Health Clin. 2018 Mar 23;7(3):111-115. doi: 10.9740/mhc.2017.05.111. eCollection 2017 May. PubMed PMID: 29955508; PubMed Central PMCID: PMC6007566.
19. Coe AB, Bostwick JR, Choe HM, Thompson AN. Provider perceptions of pharmacists providing mental health medication support in patient-centered medical homes. J Am Pharm Assoc (2003). 2019 Jul - Aug;59(4):555-559. doi: 10.1016/j.japh.2019.03.002. Epub 2019 Apr 19. PubMed PMID: 31010786; PubMed Central PMCID: PMC6625839.
20. Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003 Dec;23(12):1634-44. Review. PubMed PMID: 14695043.
21. Rubio-Valera M, Chen TF, O'Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014 Oct 21;11(10):10967-90. doi: 10.3390/ijerph111010967. Review. PubMed PMID: 25337943;  PubMed Central PMCID: PMC4211017.
22. Goodman CS, Smith TJ, LaMotte JM. A survey of pharmacists' perceptions of the  adequacy of their training for addressing mental health-related medication issues. Ment Health Clin. 2018 Mar 23;7(2):69-73. doi: 10.9740/mhc.2017.03.069. eCollection 2017 Mar. PubMed PMID: 29955501; PubMed Central PMCID: PMC6007666.
23. Skoglund I, Björkelund C, Svenningsson I, Petersson EL, Augustsson P, Nejati S, Ariai N, Hange D. Influence of antidepressant therapy on sick leave in primary care: ADAS, a comparative observational study. Heliyon. 2019 Jan 4;5(1):e01101. doi: 10.1016/j.heliyon.2018.e01101. eCollection 2019 Jan. PubMed PMID: 30627686;  PubMed Central PMCID: PMC6321886.
24. Guillaumie L, Ndayizigiye A, Beaucage C, Moisan J, Grégoire JP, Villeneuve D,  Lauzier S. Patient perspectives on the role of community pharmacists for antidepressant treatment: A qualitative study. Can Pharm J (Ott). 2018 Feb 9;151(2):142-148. doi: 10.1177/1715163518755814. eCollection 2018 Mar-Apr. PubMed PMID: 29531632; PubMed Central PMCID: PMC5843116.
25. Srimongkon P, Aslani P, Chen TF. Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study. Patient Prefer Adherence. 2018 Sep 19;12:1863-1873. doi: 10.2147/PPA.S160728. eCollection 2018. PubMed PMID: 30288027; PubMed Central PMCID: PMC6159805.
26. Holvast F, Oude Voshaar RC, Wouters H, Hek K, Schellevis F, Burger H, Verhaak  PFM. Non-adherence to antidepressants among older patients with depression: a longitudinal cohort study in primary care. Fam Pract. 2019 Jan 25;36(1):12-20. doi: 10.1093/fampra/cmy106. PubMed PMID: 30395196.
27. Florea I, Danchenko N, Brignone M, Loft H, Rive B, Abetz-Webb L. The effect of vortioxetine on health-related quality of life in patients with major depressive  disorder. Clin Ther. 2015 Oct 1;37(10):2309-2323.e6. doi: 10.1016/j.clinthera.2015.08.008. Epub 2015 Sep 4. PubMed PMID: 26346592.
28. Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012;6:369-88. doi: 10.2147/PPA.S29716. Epub 2012 May 1. PubMed PMID: 22654508; PubMed Central PMCID: PMC3363299.
29. Kirschbaum M, Peterson G, Bridgman H. Mental health first aid training needs of Australian community pharmacists. Curr Pharm Teach Learn. 2016 May - Jun;8(3):279-288. doi: 10.1016/j.cptl.2016.02.015. Epub 2016 Mar 21. PubMed PMID: 30070236.
30. Murphy AL, Gardner DM. Pharmacists' acceptability of a men's mental health promotion program using the Theoretical Framework of Acceptability. AIMS Public Health. 2019 Jun 27;6(2):195-208. doi: 10.3934/publichealth.2019.2.195. eCollection 2019. PubMed PMID: 31297404; PubMed Central PMCID: PMC6606526.
31. Aaltonen SE, Laine NP, Volmer D, Gharat MS, Muceniece R, Vitola A, Foulon V, Desplenter FA, Airaksinen MS, Chen TF, Bell JS. Barriers to medication counselling for people with mental health disorders: a six country study. Pharm Pract (Granada). 2010 Apr;8(2):122-31. Epub 2010 Mar 15. PubMed PMID: 25132880; PubMed Central PMCID: PMC4133066.
32. American Pharmacists Association; National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of  an MTM service model (version 2.0). J Am Pharm Assoc (2003). 2008 May-Jun;48(3):341-53. doi: 10.1331/JAPhA.2008.08514. PubMed PMID: 18595820.
33. Chavez B, Kosirog E. Impact on an integrated psychiatric pharmacy service in a primary care clinic. Ment Health Clin. 2019 Jul 1;9(4):269-274. doi: 10.9740/mhc.2019.07.269. eCollection 2019 Jul. PubMed PMID: 31293846; PubMed Central PMCID: PMC6607947.
34. Bingham J, Axon DR, Scovis N, Taylor AM. Evaluating the Effectiveness of Clinical Pharmacy Consultations on Nutrition, Physical Activity, and Sleep in Improving Patient-Reported Psychiatric Outcomes for Individuals with Mental Illnesses. Pharmacy (Basel). 2018 Dec 22;7(1). pii: E2. doi: 10.3390/pharmacy7010002. PubMed PMID: 30583547; PubMed Central PMCID: PMC6473796.
35. Riley TB, Alemagno S. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients. Res Social Adm Pharm. 2019 Aug;15(8):986-991. doi: 10.1016/j.sapharm.2019.01.002. Epub 2019 Jan  7. PubMed PMID: 30665825.
36. Eltorki Y, Abdallah O, Omar N, Zolezzi M. Perceptions and expectations of health care providers towards clinical pharmacy services in a mental health hospital in Qatar. Asian J Psychiatr. 2019 Apr;42:62-66. doi: 10.1016/j.ajp.2019.03.018. Epub 2019 Mar 26. PubMed PMID: 30965189.
37. El-Den S, Chen TF, Moles RJ, O'Reilly C. Assessing Mental Health First Aid Skills Using Simulated Patients. Am J Pharm Educ. 2018 Mar;82(2):6222. doi: 10.5688/ajpe6222. PubMed PMID: 29606711; PubMed Central PMCID: PMC5869753.
38. Murphy AL, Phelan H, Haslam S, Martin-Misener R, Kutcher SP, Gardner DM. Community pharmacists' experiences in mental illness and addictions care: a qualitative study. Subst Abuse Treat Prev Policy. 2016 Jan 28;11:6. doi: 10.1186/s13011-016-0050-9. PubMed PMID: 26821700; PubMed Central PMCID: PMC4730654.
39. Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review. Ment Health Clin. 2016 Jun 29;6(4):191-196. doi: 10.9740/mhc.2016.07.191. eCollection  2016 Jul. PubMed PMID: 29955469; PubMed Central PMCID: PMC6007725.
40. Higgins A, Nash M, Lynch AM. Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthc Patient Saf. 2010;2:141-50. doi: 10.2147/DHPS.S7634. Epub 2010 Sep 9. PubMed PMID: 21701626; PubMed Central PMCID: PMC3108697.
41. Clayton AH, Croft HA, Handiwala L. Antidepressants and sexual dysfunction: mechanisms and clinical implications. Postgrad Med. 2014 Mar;126(2):91-9. doi: 10.3810/pgm.2014.03.2744. Review. PubMed PMID: 24685972.
42. Baldwin DS, Foong T. Antidepressant drugs and sexual dysfunction. Br J Psychiatry. 2013 Jun;202:396-7. doi: 10.1192/bjp.bp.112.110650. PubMed PMID: 23732933.
43. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA. 2003 Jan 1;289(1):56-64. PubMed PMID: 12503977.
44. Locke A, Kamo N. Utilizing clinical pharmacists to improve delivery of evidence-based care for depression and anxiety in primary care. BMJ Qual Improv Rep. 2016 Jul 8;5(1). pii: u211816.w4748. doi: 10.1136/bmjquality.u211816.w4748.  eCollection 2016. PubMed PMID: 27493753; PubMed Central PMCID: PMC4964234.
45. Chowdhary A, Zlotnikova V, Lucas C, Lonie JM. How do mental health first aid ™ interventions influence patient help-seeking behaviours? A dilemma for pharmacist mental health first aid responders. Res Social Adm Pharm. 2019 Jan;15(1):106-108. doi: 10.1016/j.sapharm.2018.02.010. Epub 2018 Feb 27. PubMed PMID: 29530479.
46. Latzman NE, Ringeisen H, Forman-Hoffman VL, Munoz B, Miller S, Hedden SL. Trends in mental health service use by age among adults with serious mental illness. Ann Epidemiol. 2019 Feb;30:71-73. doi: 10.1016/j.annepidem.2018.11.011.  Epub 2018 Nov 29. PubMed PMID: 30578125.
47. Douglass M, Moy B. Evaluation of the impact of a social media-focused intervention on reducing mental health stigma among pharmacy students. Ment Health Clin. 2019 May 10;9(3):110-115. doi: 10.9740/mhc.2019.05.110. eCollection  2019 May. PubMed PMID: 31123657; PubMed Central PMCID: PMC6513054.
48. Taylor DA, Nicholls GM, Taylor ADJ. Perceptions of Pharmacy Involvement in Social Prescribing Pathways in England, Scotland and Wales. Pharmacy (Basel). 2019 Mar 4;7(1). pii: E24. doi: 10.3390/pharmacy7010024. PubMed PMID: 30836693; PubMed Central PMCID: PMC6473812.
49. Alderman CP, Lucca JM. Psychiatry and clinical pharmacy: A logical partnership. Indian J Psychiatry. 2017 Apr-Jun;59(2):138-140. doi: 10.4103/psychiatry.IndianJPsychiatry_205_17. PubMed PMID: 28827857; PubMed Central PMCID: PMC5547851.
50. Tallian KB, Hirsch JD, Kuo GM, Chang CA, Gilmer T, Messinger M, Chan P, Daniels CE, Lee KC. Development of a pharmacist-psychiatrist collaborative medication therapy management clinic. J Am Pharm Assoc (2003). 2012;52(6):e252-8. doi: 10.1331/JAPhA.2012.11215. PubMed PMID: 23229987.
51. Herbert C, Winkler H. Impact of a clinical pharmacist-managed clinic in primary care mental health integration at a Veterans Affairs health system. Ment  Health Clin. 2018 Apr 26;8(3):105-109. doi: 10.9740/mhc.2018.05.105. eCollection  2018 May. PubMed PMID: 29955554; PubMed Central PMCID: PMC6007641.